ROCKVILLE, Md.--(BUSINESS WIRE)--June 22, 2006--Celera Genomics (NYSE:CRA - News), an Applera Corporation business, today plans to provide analysts and investors with an overview of its strategy for the business following the recent integration of Celera Diagnostics into Celera Genomics, and to update the investment community on the status of key products and development programs. Celera management, led by Kathy Ordonez, President of Celera, will present its strategy for growth, and as part of this presentation, will update its outlook for cash and short-term investments and end-user sales for fiscal year 2006 and provide its financial and business outlook for fiscal 2007.
